id: melatonin_supplementation_to_insomnia_severity_isi
name: Melatonin Supplementation (10mg) â†’ Insomnia Severity (ISI Score)
from_node:
  node_id: melatonin_supplementation
  node_name: Melatonin Supplementation (10mg)
to_node:
  node_id: insomnia_severity_isi
  node_name: Insomnia Severity (ISI Score)
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Melatonin modulates sleep-wake cycle through chronobiotic effects on circadian
  rhythm'
- 'Step 2: Reduced sleep latency and fewer nighttime awakenings decrease insomnia
  symptoms'
- 'Step 3: Improved sleep continuity reduces perceived insomnia severity'
- 'Step 4: ISI scores decrease reflecting subjective improvement in insomnia symptoms'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Tahereh Madani Motlaq et al. 2024. "Effect of melatonin on insomnia
    and daytime sleepiness, in patients with obstructive sleep apnea and insomnia
    (COMISA): A randomized double-blinded placebo-controlled trial." *Journal of Pharmaceutical
    Health Care and Sciences*. https://doi.org/10.1186/s40780-024-00347-9'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.022537'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: comorbid_osa
  direction: strengthens
  strength: moderate
  description: All participants had comorbid OSA with PAP therapy, suggesting melatonin's
    effectiveness may be enhanced when treating insomnia in context of managed sleep-disordered
    breathing
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/melatonin_supplementation_to_insomnia_severity_isi.yaml
_category: healthcare_access
